Drugs / rMal d 1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01449786 | Mar 2012 → Feb 2014 | — | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rMal d 1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01449786 ↗ |
| Modality | Protein / enzyme biologic | “25µg recombinant Major apple allergen, Mal d 1” NCT01449786 ↗ |